Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-042376
Filing Date
2021-06-22
Accepted
2021-06-22 16:06:26
Documents
2
Period of Report
2021-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1560
2 POA DOCUMENT poa.txt EX-24.3_994740 3746
  Complete submission text file 0001209191-21-042376.txt   6705
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Business Address
Souza Marcio (Reporting) CIK: 0001707657 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37722 | Film No.: 211035263